172 related articles for article (PubMed ID: 12867626)
1. IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system.
Gherardi MM; Ramírez JC; Esteban M
J Gen Virol; 2003 Aug; 84(Pt 8):1961-1972. PubMed ID: 12867626
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 17 modulates the immune response to vaccinia virus infection.
Patera AC; Pesnicak L; Bertin J; Cohen JI
Virology; 2002 Jul; 299(1):56-63. PubMed ID: 12167341
[TBL] [Abstract][Full Text] [Related]
3. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 mediates potent antiviral responses via an interferon-dependent mechanism.
Foong YY; Jans DA; Rolph MS; Gahan ME; Mahalingam S
Virology; 2009 Oct; 393(2):228-37. PubMed ID: 19729181
[TBL] [Abstract][Full Text] [Related]
5. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Ohashi K; Ikeda M; Kurimoto M
Cytokine; 1999 Aug; 11(8):593-9. PubMed ID: 10433806
[TBL] [Abstract][Full Text] [Related]
6. Effects of virally expressed interleukin-10 on vaccinia virus infection in mice.
Kurilla MG; Swaminathan S; Welsh RM; Kieff E; Brutkiewicz RR
J Virol; 1993 Dec; 67(12):7623-8. PubMed ID: 8230481
[TBL] [Abstract][Full Text] [Related]
7. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2.
Karupiah G; Coupar BE; Andrew ME; Boyle DB; Phillips SM; Müllbacher A; Blanden RV; Ramshaw IA
J Immunol; 1990 Jan; 144(1):290-8. PubMed ID: 2295796
[TBL] [Abstract][Full Text] [Related]
8. CD69 Deficiency Enhances the Host Response to Vaccinia Virus Infection through Altered NK Cell Homeostasis.
Notario L; Alari-Pahissa E; de Molina A; Lauzurica P
J Virol; 2016 Jul; 90(14):6464-6474. PubMed ID: 27147744
[TBL] [Abstract][Full Text] [Related]
9. Evaluating vaccinia virus cytokine co-expression in TLR GKO mice.
Sutherland DB; Ranasinghe C; Regner M; Phipps S; Matthaei KI; Day SL; Ramshaw IA
Immunol Cell Biol; 2011 Aug; 89(6):706-15. PubMed ID: 21173782
[TBL] [Abstract][Full Text] [Related]
10. The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36/LACK.
Tapia E; Pérez-Jiménez E; López-Fuertes L; Gonzalo R; Gherardi MM; Esteban M
Microbes Infect; 2003 Feb; 5(2):73-84. PubMed ID: 12650765
[TBL] [Abstract][Full Text] [Related]
11. Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.
Abboud G; Tahiliani V; Desai P; Varkoly K; Driver J; Hutchinson TE; Salek-Ardakani S
J Virol; 2016 Jan; 90(1):129-41. PubMed ID: 26468539
[TBL] [Abstract][Full Text] [Related]
12. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice.
Karupiah G; Woodhams CE; Blanden RV; Ramshaw IA
J Immunol; 1991 Dec; 147(12):4327-32. PubMed ID: 1684375
[TBL] [Abstract][Full Text] [Related]
13. The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor.
Lidbury BA; Ramshaw IA; Sambhi SK
Cytokine; 1995 Feb; 7(2):157-64. PubMed ID: 7780035
[TBL] [Abstract][Full Text] [Related]
14. Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells.
Selin LK; Santolucito PA; Pinto AK; Szomolanyi-Tsuda E; Welsh RM
J Immunol; 2001 Jun; 166(11):6784-94. PubMed ID: 11359837
[TBL] [Abstract][Full Text] [Related]
15. Use of recombinant viruses to deliver cytokines influencing the course of experimental bacterial infection.
Cheers C; Janas M; Ramsay A; Ramshaw I
Immunol Cell Biol; 1999 Aug; 77(4):324-30. PubMed ID: 10457199
[TBL] [Abstract][Full Text] [Related]
16. IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2.
van Den Broek M; Bachmann MF; Köhler G; Barner M; Escher R; Zinkernagel R; Kopf M
J Immunol; 2000 Jan; 164(1):371-8. PubMed ID: 10605032
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide.
Gherardi MM; Ramírez JC; Esteban M
J Virol; 2000 Jul; 74(14):6278-86. PubMed ID: 10864637
[TBL] [Abstract][Full Text] [Related]
18. IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17.
Kohyama S; Ohno S; Isoda A; Moriya O; Belladonna ML; Hayashi H; Iwakura Y; Yoshimoto T; Akatsuka T; Matsui M
J Immunol; 2007 Sep; 179(6):3917-25. PubMed ID: 17785829
[TBL] [Abstract][Full Text] [Related]
19. Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.
Legrand FA; Verardi PH; Jones LA; Chan KS; Peng Y; Yilma TD
J Virol; 2004 Mar; 78(6):2770-9. PubMed ID: 14990697
[TBL] [Abstract][Full Text] [Related]
20. Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice.
Perera LP; Goldman CK; Waldmann TA
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5146-51. PubMed ID: 11296252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
